Huizenga Theodore Alan 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Huizenga Theodore Alan（CIK 1603347）在 1 家公司共报告 8 笔 SEC Form 4 内部人交易（最近一笔 2026-09-15）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-15 | Ultragenyx Pharmaceutical Inc. (RARE) | SVP, Chief Accounting Officer | 卖出 | 1,283 | $17,410 |
| 2026-09-08 | Ultragenyx Pharmaceutical Inc. (RARE) | SVP, Chief Accounting Officer | 卖出 | 161 | $2,252 |
| 2026-04-24 | Ultragenyx Pharmaceutical Inc. (RARE) | SVP, Chief Accounting Officer | 买入 | 20,241 | $0 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | SVP, Chief Accounting Officer | 卖出 | 148 | $3,462 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | SVP, Chief Accounting Officer | 卖出 | 1,632 | $37,210 |
| 2025-12-30 | Ultragenyx Pharmaceutical Inc. (RARE) | SVP, Chief Accounting Officer | 卖出 | 85 | $2,922 |
| 2025-09-19 | Ultragenyx Pharmaceutical Inc. (RARE) | SVP, Chief Accounting Officer | 卖出 | 64 | $1,867 |
| 2025-09-08 | Ultragenyx Pharmaceutical Inc. (RARE) | SVP, Chief Accounting Officer | 卖出 | 84 | $2,637 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15